Technological developments in the field of genomic sequencing is expected to cause a decline in the cost of sequencing per base pair and thereby, greatly enhance adoption and usage rates of next generation sequencing over the forecast period.

The next generation sequencing based oncology market is expected to lead the market in terms of revenue throughout the forecast period. However, the use of NGS in fields of HLA and prenatal testing are expected to grow at a relatively higher rate through to 2022, owing to the introduction of techniques which can enable researchers to acquire phase-resolved HLA and prenatal sequences in single cycle reads. In addition, recent developments are expected to solve sequencing ambiguity issues and provide greater insights about genetic functioning.

With this expected increase in usage of whole genome sequencing, a consequent increase in revenue from HLA and prenatal testing segments is also expected, owing to the introduction of more informative novel phase resolved single cycle reads. Growing incidences of cancer and infectious diseases are further expected to fuel the growth of the next generation sequencing market over the forecast period.

Browse Detailed Report with TOC at:
http://www.hexareports.com/report/next-generation-sequencing-market-analysis-by-application-hla-testing-prenatal-testing-oncology-idiopathic-amp-infectious-diseases-by-technology-whole-genome-sequencing-whole-exon-sequencing-targeted-sequencing-amp-resequencing-by-workflow-ngs-pre-sequencing-ngs-sequencing-ngs-data-analysis-and-segment-forecasts-to-2022/details

Further key findings from the study suggest:

Targeted sequencing & resequencing was the leading technology segment of the market in 2014, majorly owing to rapidly growing demand in oncology and infectious diseases related research. Sequencing of targeted genes allows researchers to gain insights into the functioning of cancer cells and pathogenic life cycles. Growing incidences of life threatening forms of cancer and infectious diseases is a high impact rendering factor expected to contribute to the growth of this segment over the forecast period.

Next generation sequencing was the largest workflow segment of the market in 2014. The introduction of technologically advanced genome sequencing platforms and the growing demand for personalized medicine are two factors likely to drive segment growth over the forecast period.

Next generation sequencing based data analysis is also expected to grow at a considerably high rate during the forecast period. Large amounts of sequencing data generated from extensive R&D initiatives and the subsequent growth in demand for storage and analysis are some factors attributing to the segment’s rapid growth.

Browse Biotechnology Related Reports by Hexa Research Inc. at:
http://www.hexareports.com/category/biotechnology-market

North America emerged as the leading regional market in 2014. High R&D investment directed towards the development of genome sequencing, presence of sophisticated technology framework, increasing adoption rates of whole genome sequencing and the reduction in cost of sequencing per base pair are some factors accounting for the region’s large market share. Key participants of the next generation sequencing market include GATC Biotech AG., Life Technologies (Thermo Fisher Scientific), 454 Life Sciences Corp. (Roche Holding AG), Pacific Biosciences, Agilent Technologies Inc., Macrogen Inc., Beijing Genomics Institute, Biomatters Ltd., CLC bio (Qiagen), Illumina Inc., DNASTAR Inc., Knome Inc., Qiagen NV., Helicos BioSciences, and Oxford Nanopore Technologies.

For the purpose of this study, Grand View Research has segmented the next generation sequencing market on the basis of technology, workflow, application and region:

Request a Sample Copy of this Report at:
http://www.hexareports.com/sample/42594

Global Next Generation Sequencing Application Outlook (Revenue, USD Billion, 2012 – 2022)

HLA Testing
Prenatal Testing
Oncology
Idiopathic Diseases
Infectious Diseases
Others

Global Next Generation Sequencing Technology Outlook (Revenue, USD Billion, 2012 – 2022)

Whole Genome Sequencing
Whole Exon Sequencing
Targeted Sequencing & Resequencing

For More Details on this Report, Visit:
http://www.hexareports.com/report/next-generation-sequencing-market-analysis-by-application-hla-testing-prenatal-testing-oncology-idiopathic-amp-infectious-diseases-by-technology-whole-genome-sequencing-whole-exon-sequencing-targeted-sequencing-amp-resequencing-by-workflow-ngs-pre-sequencing-ngs-sequencing-ngs-data-analysis-and-segment-forecasts-to-2022/details

About Us:

Hexa Research Inc. (http://www.hexareports.com) is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1443087559.png

Media Contact
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Email: sales@hexareports.com
Phone: 1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexareports.com/report/next-generation-sequencing-market-analysis-by-application-hla-testing-prenatal-testing-oncology-idiopathic-amp-infectious-diseases-by-technology-whole-genome-sequencing-whole-exon-sequencing-targeted-sequencing-amp-resequencing-by-workflow-ngs-pre-sequencing-ngs-sequencing-ngs-data-analysis-and-segment-forecasts-to-2022/details

Source: ABNewswire

ReleaseID: 38395

September 24, 2015 – – Banville Law reports that millions of men across the United States are using testosterone therapy to treat something termed “low-T.” Low T is used to describe symptoms associated with the natural decline in testosterone all men experience as they age.

As testosterone declines, it can produce some unwelcome side effects, such as loss of libido, muscle mass, and bone density, and weight gain, irritability, fatigue or insomnia. While this is a normal part of aging, it is alleged that manufacturers of low testosterone therapies approved for treatment of hypogonadism, have also been targeting these men.

Current legal claims surrounding the controversial treatments state that, especially for men without hypogonadism, these low t drugs can cause several health risks, ranging from heart attacks, blood clots, strokes, and death.

On January 31st of 2014, the United States Food and Drug Administration made announcements stating that it would begin investigating the prescription low testosterone products. This investigation was spurred after two studies were published linking low testosterone therapy treatments to an increased risk of pulmonary embolism, deep vein thrombosis, heart attacks, strokes, and death.

During one of these studies, the National Cancer Institute profiled more than 55,000 men with lowered testosterone levels. It was noted that when some of these men used low testosterone drugs, they were at increased risk of suffering from cardiac problems including heart attacks. Additionally, it was noted that men ages 65 and older seemed to double their heart attack risk within only the first three months of using their low testosterone treatments.

Low Testosterone therapy drugs come in a variety of forms, including injections, gels/creams, and pills. They also come under many brand names and are marketed through several manufacturers. AndroGel is the most commonly used low T medication, but there are several others to be aware of: Androderm, Axiron, Bio-T-Gel, Delatestryl, Fortesta, Striant, Testim, and Testopel.

Currently, over 2,500 legal claims have been filed against the manufacturers of many of these treatments. The claims have been consolidated to form an MDL (or Multidistrict Litigation) in the U.S. District Court for the Northern District of Illinois. Discovery is ongoing for the MDL and dates for bellwether trials will soon be set. They will be overseen by the Honorable Judge Matthew F. Kennelly.

Anyone who has suffered serious health complications after being prescribed a low testosterone treatment may be entitled to a lawsuit and compensation. Laurence Banville, Esq. of Banville Law is currently working to help individuals who would like to explore their legal options. He also sponsors LowTestosteroneCase.com, where people can find more details regarding low testosterone lawsuits and their rights.

Call 917-809-6595 anytime to speak with Laurence Banville, Esq. directly and get the assistance you deserve.

###

Contact Banville Law:

Laurence Banville, Esq.
888-478-9711
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60004364

Synthetic biology market is expected to grow over the forecast period owing to the increasing uses of environmental applications such as biodegradation, contaminants, detection of environmental pathogens, distinct chemicals immobilization, and bio-transformation.

The Synthetic Biology Market growth drivers of this market are lifestyle induced diseases such as obesity & diabetes, molecular biology advancement, increase demand for biofuels, sophisticated healthcare infrastructure, increasing geriatric population rising demand for improved drugs and vaccines, due to increasing population demand for genetically modified crops are also rising and awareness. These factors are expected to drive the market over the forecast period. Synthetic biology refer as introduction of novel engineering systems, biological based parts, devices and redesigning of existing biological parts.

Biological systems production can be increased with the help of new preferred functions by developing genetically modified organisms. Bioscience has witnessed the revolution by the introduction of synthetic biology as it makes new biological parts, systems and devices with the help of engineering principles. In commercial market, synthetic biology is in nascent stage as it is newly introduced in it. Grocery and departmental store shelves contains the consumer products of which ingredients made by using advanced form of engineering.

Browse Detailed Report with TOC at:
http://www.hexaresearch.com/research-report/synthetic-biology-industry/

Synthetic biology market apart from its original aim .i.e. manufacturing of biofuels has recently extended its function in the area of industries such as cosmetics, flavorings and scents. Due to deforestation and habitat destruction there is a huge pressure on ecosystem, so with the help of molecular biology and industrial fermentation procedure are used in the production of renewable algal oils which will reduce the pressure on ecosystem. Under life sciences, the most vital role of synthetic biology is the development of cheap synthesis procedure. With the help of synthetic biology there has been development in sources of green energy, improvement of food crops, medicines and bio based chemicals. Due to the decrease in the price of DNA sequencing the cost of data generation has fallen drastically. Synthetic biology market has a huge opportunity over the forecast period owing to various investments by the government in this sector.

Product Insights

Synthetic biology market is segmented on the basis of product types into DNA synthesis, enabling product oligonucleotide synthesis, chassis organisms XNA, synthetic cells, synthetic DNA, synthetic genes, and core product. Among these, synthetic DNA held the largest market share in 2013 owing to high commercialization and more R&D.

Browse Biotechnology Related Reports by Hexa Research Inc. at:
http://www.hexaresearch.com/research-category/biotechnology-industry/

Application Insights

Synthetic biology market is segmented on the basis of application into energy & environment, biosecurity, R&D, healthcare, bio fuels, chemicals, and agriculture. Among these, healthcare application held the largest market share in 2013, owing to effective production of nutraceuticals for preservatives, vitamins and supplements, new therapeutic method, reprogramming stem cells, and regenerative medicine.

Technology Insights

Synthetic biology market is segmented on the basis of technology into bioinformatics, integrated systems, biological components, genome engineering, and DNA sequencing. Among these, genome engineering held the largest market share in 2013, owing to its developed strategies and techniques.

Request a Sample Copy of this Report at:
http://www.hexaresearch.com/sample/213

Regional Insights

Geographically, the synthetic biology market is studied with respect to four regions such as Asia Pacific, Europe, North America, and RoW. Among these, North America is dominating the whole market in 2013, as it has presence of technologically updated systems, strong research & development, various government initiatives & programs and high patient awareness levels in this region. The growing economies in Asia Pacific such as India and China region are expected to witness lucrative growth over the forecast period owing to the rising healthcare expenditure, and awareness about the hospital acquired infection.

Competitive Insights

The major market players in the synthetic biology market are New England Biolabs, Inc., Cobalt Technologies, DuPont, Inc., Evolva SA, Exxon Mobil Corporation, Ginkgo Bioworks, GeneWorks Pty Ltd., Gene Script Corporation, Biosearch Technologies, Inc., Bristol-Myers Squibb, Bioneer Corporation, CBC Comprehensive Biomarker Center GmbH, ATG:biosynthetics GmbH, Bayer AG, Algenol Biofuels, Inc., Agrivida, Inc., Amyris Inc.

For More Details on this Report, Visit:
http://www.hexaresearch.com/research-report/synthetic-biology-industry/

About Us:

Hexa Research Inc. (http://www.hexaresearch.com) is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1443086967.jpeg

Media Contact
Company Name: Hexa Research
Contact Person: Michelle Thoras and Ryan Shaw
Email: sales@hexaresearch.com
Phone: +1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexaresearch.com/research-report/synthetic-biology-industry/

Source: ABNewswire

ReleaseID: 38393

September 24, 2015 – – Blacksburg, Virginia based Cryptonomex has announced that they will be presenting at the upcoming Dublin Web Summit in November. The summit is scheduled to take place from November 3 until November 5, 2015. “We’re honored to be invited and proud to be a part of such a huge collaboration of people in our industry,” states Stan Larimer, spokesperson for Cryptonomex.

The Web Summit has become one of the most influential technology based events in the world, just four short years after its inception. The November summit will showcase more than 500 speakers and include 10 stages for a number of industries such as digital marketing, internet, enterprise, and builders. More than 2,000 startups from around the world have been invited to set up exhibits to showcase their work.

With more than 1,000 experienced investors, more than 200 satellite events, and around 800 tech journalists, the three day event is expected to make Dublin the tech capital of the world.

The 2014 event included more than 20,000 attendees, and had some rather big name executives from Google, Facebook, Microsoft and a number of Fortune 500 companies. This year’s event is expected to top 30,000 attendees and will allow for networking with people who are shaping the technology of the future.

Cryptonomex is a blockchain development company that was originally founded by the core developers of BitShares. The company facilitates growth of industrial blockchain technology, and provides software development for custom, performance, and related technology. Cryptonomex blockchains serve as platforms that can easily be integrated into different types of applications. The company can assist with building blockchain based applications from scratch, or integrate existing applications to be better updated with current technology.

“We are looking forward to showing the world what we can do,” states Larimer. “This is a huge seminar with a lot of people from all over the world that share our interests, and to be invited to be part of it is very exciting.”

More about the company, including a complete list of the services that they can provide, can be seen on their official website.

###

Contact Cryptonomex:

Stan Larimer, President
stan@cryptonomex.com
2020 Kraft Drive
Suite 3040
Blacksburg, VA 24060

ReleaseID: 60004254

Developing or making new products with the help of living organisms is known as Biotechnology. It is basically a technological application which uses living/biological system to produce products for specific purposes.

Biotechnology market is also used in recycling, treating the biological wastes and making biological weapons. Developing nations possess a huge potential market for biotechnology owing to the continuous gaining popularity of biotechnological products and high effectiveness. There is a huge gap between the demand and supply of biotechnological products which is needed to be served over the forecast period. Flourishing stem cell research is also likely to propel the growth of biotechnology market in coming few years.

Heavy investment by biotechnological companies resulting in discovery of advanced biological products is likely to drive the market in the coming five years. Increasing usage in therapeutics, commercial application and basic research are the factors expected to trigger the growth of biotechnology market over the forecast period. The instruments of biotechnology market is also likely to witness lucrative growth owing to increasing number of biotechnology firms all over the world and huge expenditure in sunk cost.

Browse Detailed Report with TOC at:
http://www.hexaresearch.com/research-report/biotechnology-industry/

Technology Insights

By technology, the global biotechnology market is divided into nanobiotechnology, DNA sequencing, tissue engineering and regeneration, PCR technology, chromatography, fermentation, and cell based array. Tissue engineering and regeneration was dominating the entire biotechnology market in 2013. Owing to improving the damaged tissues or the entire organ and usage of biologically active molecules to improve the functions, this market is anticipated to witness significant growth rate over the next decade. It is basically used for targeting and creating tissues which are used for various purposes like heart muscles, bone, cartilage, nerves and blood vessels. PCR technology segment is also expected to show growth in coming five years due to its ability of amplifying DNA and make identical copies.

Application Insights

On the basis of application, the global biotechnology market is fragmented into biopharmacy, bioagricultural, bioservices and bioindustrial. Among these, the biopharmacy application market was the overall market leader in 2013 in terms of revenue. Continuous increase in demand for drugs and disposable needles to prevent chronic diseases & continuous genetic analysis is expected to push the market growth in the coming few years. Bioservice market is also anticipated to witness lucrative growth over the forecast period owing to the involvement of preclinical and clinical researches which are prescribed by regulatory authorities following certain standards. Huge investment in sunk cost by big pharmacies and government resulting in reduction of clinical trial duration is also likely to push the demand for this market in future.

Browse Biotechnology Related Reports by Hexa Research Inc. at:
http://www.hexaresearch.com/research-category/biotechnology-industry/

Regional Insights

In 2013, North America was the most dominant market of biotechnology and expected to continue its lead over the forecast period. Due to presence of sophisticated healthcare infrastructure, growing level of awareness among people and high rate of reimbursement medical policies, this market will continue to grow in the next decade. Furthermore, free pricing nature in pharmacies market due to the strict norms relating to patents is also expected to drive this market. Asia Pacific region is expected to be the fastest growing segment due to strong government support, increasing disposable income resulting in rising healthcare expenditure, and large potential market.

Request a Sample Copy of this Report at:
http://www.hexaresearch.com/sample/56

Competitors Insights

Novo Nordisk, BiogenIdic, Gilead Sciences, Merck KGaA, Amgen, United Therapeutics, Celgene, Teva Pharmaceutical Industries, Regeneron, CSL, Vertex Pharmaceuticals, Alexion Pharmaceuticals, Ipsen Group, BioMarin Pharmaceutical, Shire PLC, Cubist Pharmaceuticals, Actelion, Elan, Onyx Pharmaceuticals, Dr. Reddy’s Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals and DiaSorin are the major market players of the global biotechnology market. The market is highly competitive and monopolistic in nature. Firms are going through mergers, acquisitions, new product development and geographical expansion to earn maximum revenue and gain more customers.

For More Details on this Report, Visit:
http://www.hexaresearch.com/research-report/biotechnology-industry/

About Us:

Hexa Research Inc. (http://www.hexaresearch.com) is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1443086654.jpeg

Media Contact
Company Name: Hexa Research
Contact Person: Michelle Thoras and Ryan Shaw
Email: sales@hexaresearch.com
Phone: +1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexaresearch.com/research-report/biotechnology-industry/

Source: ABNewswire

ReleaseID: 38391

The Global Genomics Market has witnessed growth in market potential due to technological advancements such as novel informatics approach that integrate many forms of information with genomic information in disease research which allowing researchers to better understand the genetic bases of various diseases and drug response.

Global Genomics Market by the certain governmental bodies, increasing incidence rate of fetal disorder such cancer, diabetes and others contribute to the increase in their demand globally. Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing on steps to implement it and rising genome profiling technologies are expected to grow the genomics market at the rapid speed. The overall genomics market is expected to grow at a CAGR of 10.0% during the forecast period.

Product Insights

Key genomic products include consumables, instruments and services. Consumables emerged as market leader holding the largest share of the market at 59.0% in 2013. It is expected to grow at the fastest CAGR of over 11.0% during the forecast period due to growing commercial usage of genomic testing for varied applications clubbed with mounting applications and reduction in cost of consumer products.

Browse Detailed Report with TOC at:
http://www.hexaresearch.com/research-report/genomics-industry/

Application Insights

Key application markets for genomics include diagnostics, personalizes medicine, drug discovery, academic research and others. Application of this in diagnostics market accounted for the largest overall revenue share at 35.7% in 2013. This is due to growing application usage of molecular diagnostic tests for disease treatment and management, increasing awareness amongst medical practitioners regarding the benefits of genetics based diagnostics and accuracy. The expected highest CAGR of personalized medicine market during the forecast period is assumed to be due to factors such as early disease prognosis, cost effective treatments, drug safety, patient compliance, and treatment optimization.

The SCGPM is striving for advancement of genomic technology for making both genetic and molecular profiling as routine tools for monitoring, disease risk prediction and treatment of diseases. North America emerged as a leader of overall personalized medicine market in 2013 due to in technology advancement and developments in the areas of genetics. Asia Pacific market of personalized medicine in 2013 is expected to grow at the highest CAGR due to development of different new technologies by research organizations leading to the improvement of the existing healthcare infrastructure and widely distributed network of clinical laboratories in India and China.

Related Reports by Hexa Research Inc.

Biotechnology Market:
http://www.hexaresearch.com/research-report/biotechnology-industry/

Synthetic Biology Market:
http://www.hexaresearch.com/research-report/synthetic-biology-industry/

Technology Insights

Key technologies studied in this study include DNA sequencing, PCR, nucleic acid extraction and purification and DNA microarray. PCR emerged as largest market share holder segment in 2013 owing to increasing R&D activities in proteomics and genomics, technology advancement and government policies interventions regarding R&D funding. Nucleic acid extraction and purification technology market is expected to flourish at the highest CAGR of over 10.0% during the forecast period due to increasing approach for new diagnostic tools and techniques, evaluation of patient benefit outcome and focusing on steps to increase implementation of genome profiling technologies.

Regional Insights

Europe, North America, Asia Pacific and RoW are the key regions analyzed in this report. Europe emerged as overall market leader of genomics market in 2013 owing to increasing incidence rate of genetic and cardiovascular disorders clubbed with increasing proteomics and genomics investments is expected to be driver for the market. However, regional growth is expected to be restrained owing to the presence of uneven reimbursement policies and economic crisis. The Asia Pacific market is expected to flourish at the highest CAGR of over 12.0% in 2014 to 2020 due to growing awareness and genomics techniques adoption in emerging economies such as India and China for prognosis and treatment of varied genetic disorders such as diabetes, cancer and others. Additionally, enhancing healthcare infrastructure, rising disposable incomes of patients and increasing healthcare expenditures are also growth drivers for this market.

Request a Sample Copy of this Report at:
http://www.hexaresearch.com/sample/56

About Us:

Hexa Research Inc. (http://www.hexaresearch.com) is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1443085985.jpeg

Media Contact
Company Name: Hexa Research
Contact Person: Michelle Thoras and Ryan Shaw
Email: sales@hexaresearch.com
Phone: +1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexaresearch.com/research-report/genomics-industry/

Source: ABNewswire

ReleaseID: 38389

September 24, 2015 – – Remittio, a multinational payment transfer service offering secure banking alternatives for spending, storing, and accepting money instantly, has announced that they will be making a presentation at the upcoming Dublin Web Summit 2015. The company explained that with the use of the most technologically advanced network, secure transaction methods are simplified with no requirements of traditional banking or additional fees. Those using the system can safely store and transmit financial assets instantly.

“Our business provides the ability to secure financial assets in a volatile world while accepting, spending, and storing money unbound by settlement options,” states Michael, a spokesperson for the company.

The Web Summit is in its fifth year, and is a conference held in Dublin that centers on internet technologies. Attendees include a number of Fortune 500 companies and executives from some of the world’s most well-known tech companies.

“We couldn’t be more honored at being asked to present,” points out Michael. “We feel that this is our chance to show the world what we’ve got.”

The web summit has grown substantially since its first meeting in 2010. With only around 400 attendees in the first year, it has well surpassed that initial meeting, with more than 22,000 attendees from over 100 different countries attending the 2014 event.

Early count suggests that attendance during the November 3rd through 5th event will surpass 30,000. The event is held in Dublin, Ireland, and is normally comprised of different summits. The 2014 event focused on machine, enterprise, builders, and marketing.

Remittio is among a number of other technology based companies that will be presenting their current and future ideas to those in attendance. The company works closely with Bitchares Blockchain Technology. This technology is an industrial grade financial platform that delivers with the speed of NASDAQ, according to the company.

Those interested in learning more about the company can visit them on their official website. For a list of key speakers and other companies planning to attend and present at the Dublin Web Summit, visit the summit’s official website, which also offers information on registration and area accommodations, as well as highlights from past events.

###

Contact Remittio:

Michael
8012590816
info@remittio.com

ReleaseID: 60004256

The changing lifestyles and increasing urbanization, and growing interest of people in tourism are the key drivers of the global luggage market. The increasing travel and tours, growing business activities, and increasing number of educational courses are further propelling the demand for luggage. The fluctuating recreation patterns and increasing disposable income of the global population are the major causes for the growth of the travel and tourism industry. The most frequent travellers across international and domestic zones are the people from countries such as the U.S., Sweden, and Finland. The travel bags segment holds a significant share of the global luggage market in all the regions, followed by the casual bags segment. The luggage market in Asia-Pacific is growing at a rapid pace, and id mainly driven by the growing markets such as China and India. Unstable raw material prices are one of the key factors hindering the global luggage market growth. Some of the materials used in luggage include plastic, aluminum, fabric, and iron. Unstable prices of these raw materials adversely affect the income margins of luggage manufacturers. The largest market for travel bags in 2014 was Asia-Pacific. The increasing leisure and travel activities are boosting the growth of the travel bags segment, in the global luggage market.

Explore Detailed ToC on “Global Luggage Market” at:
https://www.psmarketresearch.com/market-analysis/luggage-market

The product category of luggage market includes casual bags, travel bags, and business bags. The distribution channels include specialist retailers, factory outlets, and internet sales. Travel bags accounts for a fair share in North America, Europe, and Rest of the World. Amongst the distribution channels, the specialist retailer segment account for a fair share in the global luggage market. Evolving technologies in the luggage industry are expected to boost the market growth, in the forecast period. Due to growing disposable income and increasing urbanization, the lifestyle of people has changed, and the demand of purpose-based luggage has up surged. The African and Asian countries are anticipated to experience highest urban growth in the forecast period. According to the China Development Research Foundation, China’s urban population is expected to increase from 52.6% in 2012, to 70% by 2030.

Specialist retailers comprise independent retailers that solely sell luggage and related products. Asia Pacific leads the luggage sales from specialist retailers with 50.1% share in 2014. In 2012, bags, wallets, and purses were the most preferred products in the Japanese luggage market. Luggage is sold through several types of distribution channels such as factory outlets, specialist retailers, hypermarkets, supermarkets, and internet sales. Due to the boom in online commerce, the internet sales of luggage have been growing at a considerable pace.

Ask for Report Sample at:
https://www.psmarketresearch.com/enquiry-form.php?enqid=462&title=Report%20sample

The younger generation, including students and sportsmen, mostly use casual bags. Number of students pursuing higher education is increasing, which in turn, is boosting the demand for casual bags. China, India, South Korea, Germany, Turkey, and France are the major countries, which involve high adoption of tertiary education. Annual per capita disposable income of urban households in China increased from USD 2,818.6 in 2010, to USD 4,692.9 in 2014, according to the National Bureau of Statistics of China.

The major companies operating in the global luggage market include Samsonite International S.A. Inc., Tumi Holdings Inc., VIP Industries Ltd., VF Corporation, Briggs & Riley Travelware, Rimowa GmbH, MCM Worldwide, and Louis Vuitton Malletier S.A.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1443085838.jpeg

Media Contact
Company Name: P&S Market Research
Contact Person: Ms Somya, Manager – Client Partner
Email: enquiry@psmarketresearch.com
Phone: +1-888-778-7886 (USA/Canada Toll-Free)
Address:347, 5th Ave. #1402
City: New York City
State: NY
Country: United States
Website: https://www.psmarketresearch.com

Source: ABNewswire

ReleaseID: 38387